BindingDB logo
myBDB logout

BDBM50091331 CHEMBL3582255::US9872852, Example 122

SMILES: Cc1c(COc2ccc(CNCC3CCC(=O)N3)cc2)cccc1-c1ccccc1

InChI Key: InChIKey=NIVJEFTUALCIHL-UHFFFAOYSA-N

Data: 3 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50091331   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Programmed cell death 1 ligand 1


(Homo sapiens (Human))
BDBM50091331
PNG
(CHEMBL3582255 | US9872852, Example 122)
Show SMILES Cc1c(COc2ccc(CNCC3CCC(=O)N3)cc2)cccc1-c1ccccc1
Show InChI InChI=1S/C26H28N2O2/c1-19-22(8-5-9-25(19)21-6-3-2-4-7-21)18-30-24-13-10-20(11-14-24)16-27-17-23-12-15-26(29)28-23/h2-11,13-14,23,27H,12,15-18H2,1H3,(H,28,29)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 101n/an/an/an/an/an/a



Therachem Research Medilab (India) Pvt. Ltd.

Curated by ChEMBL


Assay Description
Binding affinity to His-tagged PD-L1 (unknown origin) assessed as inhibition of interaction with PD1 preincubated for 15 mins followed by PD1 additio...


ACS Med Chem Lett 6: 489-90 (2015)


Article DOI: 10.1021/acsmedchemlett.5b00148
BindingDB Entry DOI: 10.7270/Q2445P63
More data for this
Ligand-Target Pair
Programmed cell death 1 ligand 1


(Homo sapiens (Human))
BDBM50091331
PNG
(CHEMBL3582255 | US9872852, Example 122)
Show SMILES Cc1c(COc2ccc(CNCC3CCC(=O)N3)cc2)cccc1-c1ccccc1
Show InChI InChI=1S/C26H28N2O2/c1-19-22(8-5-9-25(19)21-6-3-2-4-7-21)18-30-24-13-10-20(11-14-24)16-27-17-23-12-15-26(29)28-23/h2-11,13-14,23,27H,12,15-18H2,1H3,(H,28,29)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 555n/an/an/an/an/an/a



Novartis Pharmaceuticals



Assay Description
All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe...


J Med Chem 51: 4-16 (2008)


BindingDB Entry DOI: 10.7270/Q2RN3B42
More data for this
Ligand-Target Pair
Programmed cell death 1 ligand 1


(Homo sapiens (Human))
BDBM50091331
PNG
(CHEMBL3582255 | US9872852, Example 122)
Show SMILES Cc1c(COc2ccc(CNCC3CCC(=O)N3)cc2)cccc1-c1ccccc1
Show InChI InChI=1S/C26H28N2O2/c1-19-22(8-5-9-25(19)21-6-3-2-4-7-21)18-30-24-13-10-20(11-14-24)16-27-17-23-12-15-26(29)28-23/h2-11,13-14,23,27H,12,15-18H2,1H3,(H,28,29)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 5.51E+3n/an/an/an/an/an/a



Novartis Pharmaceuticals



Assay Description
All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe...


J Med Chem 51: 4-16 (2008)


BindingDB Entry DOI: 10.7270/Q2RN3B42
More data for this
Ligand-Target Pair